View of COST EFFECTIVENESS ANALYSIS OF LETROZOLE VERSUS TAMOXIFEN IN EARLY-STAGE BREAST CANCER FOR POSTMENOPAUSAL WOMEN: SYSTEMATIC REVIEW

Return to Article Details COST EFFECTIVENESS ANALYSIS OF LETROZOLE VERSUS TAMOXIFEN IN EARLY-STAGE BREAST CANCER FOR POSTMENOPAUSAL WOMEN: SYSTEMATIC REVIEW Download Download PDF